• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 03/19/2019
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported that in-stent stenosis of mid and distal superficial femoral artery (sfa) occurred requiring additional intervention.The patient was enrolled in the eminent clinical study with the patient identifier of (b)(6).The patient underwent treatment with the eluvia stent on (b)(6) 2017 as part of the eminent clinical trial.The target lesion, located in the mid and distal sfa of the left leg, had a 5mm reference vessel diameter proximal and distal respectively, and a total length of 80mm visually estimated.The target lesion was 90% occluded and crossed through true lumen.Pre-dilatation was performed using one unspecified balloon.Afterwards an eluvia stent (6x100mm) was implanted.Post-dilatation was performed using one unspecified balloon, and 0% residual stenosis remained.On (b)(6) 2019 a re-occlusion of the target lesion left leg was observed.The patient was hospitalized on (b)(6) 2019, and an interventional procedure was performed (lysis and percutaneous transluminal angioplasty).The patient was discharged on (b)(6) 2019.The event was assessed by the investigator as serious and reported as resolved as of (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8518691
MDR Text Key142082071
Report Number2134265-2019-03496
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2018
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0019635397
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
-
-